A startup is developing “bodyoids,” brainless human-like biological systems grown from stem cells, aiming to replace animal testing and provide a future source of transplantable organs. These integrated biological structures replicate system-level biology, offering a novel platform for drug development and organ replacement, though ethical debates and significant technical challenges lie ahead.
